Search details
1.
The impact of SBF2 on taxane-induced peripheral neuropathy.
PLoS Genet
; 18(1): e1009968, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34986146
2.
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE.
Br J Cancer
; 130(8): 1348-1355, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38347093
3.
Racial Disparities in Breast Cancer: from Detection to Treatment.
Curr Oncol Rep
; 26(1): 10-20, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38100011
4.
Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Cancer
; 128(11): 2174-2181, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35285940
5.
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Br J Cancer
; 126(2): 265-274, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34616010
6.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34120223
7.
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
Breast Cancer Res
; 22(1): 131, 2020 11 30.
Article
in English
| MEDLINE | ID: mdl-33256829
8.
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis.
Lancet Oncol
; 20(3): 361-370, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30709633
9.
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Breast Cancer Res
; 21(1): 87, 2019 08 05.
Article
in English
| MEDLINE | ID: mdl-31383035
10.
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Breast Cancer Res
; 20(1): 82, 2018 08 02.
Article
in English
| MEDLINE | ID: mdl-30071865
11.
Metastatic breast cancer patients' expectations and priorities for symptom improvement.
Support Care Cancer
; 26(11): 3781-3788, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-29736866
12.
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Br J Cancer
; 126(1): 162, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34853435
13.
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?
Breast Cancer Res Treat
; 165(3): 545-553, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28646344
14.
Discerning the clinical relevance of biomarkers in early stage breast cancer.
Breast Cancer Res Treat
; 164(1): 89-97, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28401365
15.
A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.
Br J Cancer
; 114(4): 477-84, 2016 Feb 16.
Article
in English
| MEDLINE | ID: mdl-26766736
16.
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).
Br J Cancer
; 113(12): 1651-7, 2015 Dec 22.
Article
in English
| MEDLINE | ID: mdl-26625004
17.
Symptoms: Chemotherapy-Induced Peripheral Neuropathy.
Adv Exp Med Biol
; 862: 77-87, 2015.
Article
in English
| MEDLINE | ID: mdl-26059930
18.
Symptoms: Aromatase Inhibitor Induced Arthralgias.
Adv Exp Med Biol
; 862: 89-100, 2015.
Article
in English
| MEDLINE | ID: mdl-26059931
19.
Integrated and convenient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for LC-MS/MS analysis.
Proteomics
; 14(21-22): 2623-7, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25091982
20.
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.
Breast Cancer Res Treat
; 144(3): 591-7, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24584876